Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mara Labs is a life sciences company dedicated to the development of stabilized phytonutrients for therapeutic and wellness applications. The company's core innovation lies in its proprietary process for stabilizing sulforaphane, a potent inducer of the Nrf2 pathway typically known for its instability. Their flagship product, BrocElite, is positioned as a superior alternative to traditional broccoli seed extracts by delivering the active metabolite directly to the consumer. Mara Labs continues to expand its portfolio with other stabilized compounds, such as berberine and curcumin, targeting inflammation and metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mara Labs.